Strava Healthcare is a prominent and GMP-certified cyproheptadine tablets manufacturer in India; it supplies to domestic pharma companies, hospital chains, and also to export markets. Major export destination for this product is Sudan, South Sudan, Ghana, DRC Congo and Mali. Cyproheptadine is an initial-generation antihistamine with additional anti-serotonin properties that are mainly used for appetite stimulation, allergic conditions, and migraine prophylaxis. Cyproheptadine is also combined with vitamin B complex for better results.
What Cyproheptadine Is Used For
- Appetite stimulation in underweight adults and children
- Allergic rhinitis, urticaria, and perennial allergies
- Migraine and cluster headache prophylaxis
- Pruritus associated with dermatological conditions
Dosage Notes
- The standard adult dose is 4 mg three times daily.
- Paediatric dosing is completely weight-based, and it requires physician guidance.
- Drowsiness is common, particularly at treatment start; patients should be advised accordingly.
Manufacturing Quality
Each and every batch of cyproheptadine tablets is completely manufactured under GMP-certified conditions and tested for assay, dissolution, uniformity, and microbiological purity.
COAs available on request.
For B2B & Pharma Partners
- Contract Manufacturing (CMO/CDMO): tailored strengths, branding, and packaging
- Private Label: Ready to sell formulations with your brand
- Bulk Supply: For pharma distributors, hospital chains, and export markets
Product Specifications
| Parameter | Details |
|---|---|
| Active Ingredient | Cyproheptadine Hydrochloride |
| Strength | 4 mg |
| Dosage Form | Tablet |
| Pack Sizes | 10s blister, 30s bottle, 500s bulk |
| Storage | Below 30°C, away from moisture |
| Shelf Life | 36 Months |
| Manufacturer | Strava Healthcare Private Limited |
Frequently Asked Question
Short durations are standard practice. Prolonged use for appetite stimulation should be prescribed supervised by a physician due to potential side effects, including sedation and weight gain.
Indeed, at weight-appropriate doses determined by a paediatrician. Not to use in newborns or premature infants.
Yes. Appetite stimulation is a known pharmacological effect. This is the intended outcome when prescribed for underweight patients.
Yes. We supply cyproheptadine tablets to regulated and semi-regulated international markets. Dossier support and COPP available on request.